|
ABOUT COMPANY
Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company is headquartered in Cambridge, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -57355000
Market Capitalization: 810091000
Operating Margin (TTM): -0.212
PE Ratio: None
PEG Ratio: -0.11
Profit Margin: -0.218
Revenue Per Share (TTM): 1.695
Revenue (TTM): 155270000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 88.43
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.372
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -69997000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|